Drug Shortage Report for TEVA-HYDROMORPHONE

Last updated on 2020-02-13 History
Report ID 1006
Drug Identification Number 02319438
Brand name TEVA-HYDROMORPHONE
Common or Proper name HYDROMORPHONE HYDROCHLORIDE
Company Name TEVA CANADA LIMITED
Market Status MARKETED
Active Ingredient(s) HYDROMORPHONE HYDROCHLORIDE
Strength(s) 4MG
Dosage form(s) TABLET
Route of administration ORAL
Packaging size 100
ATC code N02AA
ATC description OPIOIDS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2014-11-05
Estimated end date
Actual end date 2018-08-31
Shortage status Resolved
Updated date 2020-02-13
Company comments
Health Canada comments
Contact Address 30 NOVOPHARM COURT
TORONTO, ONTARIO
CANADA M1B 2K9
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v1 2017-03-13 English Compare
v2 2017-03-13 French Compare
v3 2017-03-14 English Compare
v4 2017-03-14 French Compare
v5 2017-04-25 English Compare
v6 2017-04-25 French Compare
v7 2020-02-13 English Compare
v8 2020-02-13 French Compare